- Supply chain disruptions due to global factors
- Climate change risks (physical and transition)
- Maintaining affordability of medicines in the face of regulatory changes and increasing costs
- Ensuring access to medicines in developing countries
- Maintaining data privacy and security in a increasingly digital environment
- Managing risks related to corruption and bribery
Duopharma Biotech Berhad
Greenhouse gas emissions & sustainability report data
In its 2023 reporting, Duopharma Biotech Berhad disclosed greenhouse gas emissions of 39.6K tCO2e. By scope: Scope 1: 1.5K tCO2e; Scope 2: 38.1K tCO2e; Scope 3: 5.6K tCO2e (partial data). Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
39.6K tCO2e
2023
Water Usage
138.25 ML
2023
Waste
1.5K tons
2023
Energy Use
201.2K GJ
2023
📊 Emissions by Scope (2023)
| Scope | What it covers | Reported value |
|---|---|---|
| Scope 1 | Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions). | 1.5K tCO2e |
| Scope 2 | Indirect emissions from purchased electricity, steam, heat and cooling. | 38.1K tCO2e |
| Scope 3 | Other indirect emissions across the value chain (purchased goods, business travel, use of sold products, etc.). | 5.6K tCO2e (partial data) |
New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.
📈 Emissions by Report Period
| Report period | Headline emissions figure reported |
|---|---|
| 2023 | 39.6K tCO2e |
| 2022 | 29.4K tCO2e/year |
| 2021 | 22.8K tCO2e/year |
Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.
✅ Reported Environmental Achievements
- Achieved 0.36% reduction in total carbon emissions intensity from 2022
- 5,926.36 m3 of water recycled within operations
- Diverted 19% of non-scheduled waste from landfills
- 5.099 tonnes of biodegradable plastics used within operations to replace single-use plastics
- Increased recycling rate by 4% from 2022
- Solar panel installation at 3 main manufacturing sites
- Established GHG Scope 3 baseline data in 3 categories
🎯 Climate & Sustainability Targets
🔜 Short-term
- Reduce Scope 2 emissions by 10% annually through REC purchases
- Replace 50% of single-use plastics with biodegradable plastics by 2026
📅 Medium-term
- Achieve carbon neutrality by 2030
🔭 Long-term
- Achieve net zero carbon emissions by 2050
🌱 ESG Focus Areas
Climate PerformanceSustainable Supply ChainAccess to MedicineDiversity & InclusionGovernance